FDA Approves Herzuma for Breast Cancer

The FDA approved Herzuma, a HER2/neu receptor antagonist biosimilar to Herceptin for breast cancer treatment.

DECEMBER 17, 2018

FDA Approves Ajovy for Migraine Prevention

The FDA approved Ajovy, a humanized monoclonal antibody, for the prevention of migraine in adults. 

SEPTEMBER 18, 2018